These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6408808)

  • 1. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glibenclamide in type II diabetes as compared with placebo].
    Breier C; Lisch HJ; Drexel H; Sailer S
    Wien Klin Wochenschr; 1983 Mar; 95(6):200-3. PubMed ID: 6410589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactions between diclofenac and glibenclamide].
    Chlud K
    Z Rheumatol; 1976; 35(9-10):377-82. PubMed ID: 824884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.
    Vray M; Attali JR
    Diabete Metab; 1995 Dec; 21(6):433-9. PubMed ID: 8593925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of metipranolol on the carbohydrate metabolism in diabetics treated with glibenclamide (author's transl)].
    Knick B; Thomas L; Vollmar J; Bauer G
    Med Klin; 1979 Mar; 74(9):313-7. PubMed ID: 34084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of the interaction between tolmetin and glibenclamide.
    Chlud K; Kaik B
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):409-10. PubMed ID: 410740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of adult diabetes with semi-euglucon (author's transl)].
    Schäfer D; Molck H
    MMW Munch Med Wochenschr; 1979 Mar; 121(11):393-6. PubMed ID: 107413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases].
    Comberg HU; Janssen EJ; Diehm C; Zimmermann R; Harenberg J; Walter E; Oster P; Allenberg J; Horsch AK; Mörl H
    Vasa; 1983; 12(2):172-8. PubMed ID: 6349165
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical comparison between glibornuride (Glutril) and glibenclamide in senile diabetes. A controlled double-blind trial].
    Mogensen EF; Worm J; Mikkelsen BO
    Ugeskr Laeger; 1976 Jun; 138(26):1569-71. PubMed ID: 133484
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical comparison between glibornuride (Glutril) and glibenclamide in maturity-onset diabetes: a controlled double-blind trial.
    Mogensen EF; Worm J; Mikkelsen BO
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):559-64. PubMed ID: 132338
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes.
    Arnqvist HJ; Karlberg BE; Melander A
    Ann Clin Res; 1983; 15 Suppl 37():21-5. PubMed ID: 6433769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

  • 14. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
    Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
    J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].
    Michot F; Holt NF; Fontanilles F
    Schweiz Med Wochenschr; 1981 Feb; 111(8):255-60. PubMed ID: 7015495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.
    Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M
    Diabetes Care; 2006 Aug; 29(8):1818-25. PubMed ID: 16873786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphinpyrazone in post-myocardial infarction. Report from the Anturan Reinfarction Italian Study.
    Lancet; 1982 Jan; 1(8266):237-42. PubMed ID: 6120272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of diabetes with oral hypoglycemic agents. Controlled clinical study of 2 glibenclamide-phenformin combinations. I].
    Uccella R
    Clin Ter; 1978 Nov; 87(4):375-83. PubMed ID: 109242
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of two glibenclamide preparations, HB 419 and HB 420, in maturity-onset (type 2) diabetic patients.
    Arnala I; Uusitupa M
    Ann Clin Res; 1983; 15 Suppl 37():33-5. PubMed ID: 6433770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.